← Leaderboards
Ramya Ramaswami
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Cancer Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$591,488,216
- Leonard Freedman · Leidos Biomedical Research, Inc.$336,443,460
- Mitchell D Schnall · University Of Pennsylvania$159,596,385
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Bruce J Hillman · American College Of Radiology$116,793,338
Research focus
Cancer DiagnosisTumor SubtypeProtocols DocumentationTranscriptome SequencingPathogenicityOncologyPathway InteractionsInterleukin-12T-LymphocyteTechnologyGenomicsKaposi SarcomaCancer TherapyHuman Herpesvirus 8Cellular AssayMulticentric Angiofollicular Lymphoid HyperplasiaCytokineChemotherapyModernizationTargeted TreatmentGenomic PlatformMalignant NeoplasmsSamplingClinically Significant
Grant awards (6)
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease$957,389
ZIA · FY2025 · CA · contact PI
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease$852,381
ZIA · FY2024 · CA · contact PI
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease$559,073
ZIA · FY2023 · CA · contact PI
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease$555,331
ZIA · FY2022 · CA · contact PI
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease$458,391
ZIA · FY2021 · CA · contact PI
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease$386,692
ZIA · FY2020 · CA · contact PI